No registrations found.
ID
Source
Health condition
continuous iv, intermittend flushing, loss of funcion, neonate
continu infuus, lock, sneuvelen infuus, neonaat
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. Hours between start iv and loss of function;
2. Amount of iv lines in first 72 hours.
Secondary outcome
Side effects of continuous iv and flushing such as occlusion, infection and subcutaneous infiltration.
Background summary
Comparison of loss of function between continuous iv and intermittend flushing in neonates who need an iv for drug administration.
We expect no difference in loss of function time between continuous iv and intermittend flushing.
Other studies only compared intermittend flushing with NaCl/Heparine versus continuous glucose 10%. Seen the risk for flebitis using concentrated glucose solution we hypothesise a better outcome using glucose 5%. Because recent study shows flushing with heparin is as effective as flushing with NaCl 0,9% we use NaCl 0,9%.
Study objective
An iv that will be flushed intermittendly will not loose his function easier than a continuous iv.
Study design
1. No more need for iv drug administration;
2. 72 hours.
Intervention
1. Continuous iv glucose 5% 2ml/h;
2. Continuous iv glucose 5% 1ml/h;
3. Iv flushed 4 times a day with 2 ml NaCl 0,9%.
Frank Derriks
Venlo 5912 BL
The Netherlands
+31 (0)77 3205730
f.derriks@alumni.maastrichtuniversity.nl
Frank Derriks
Venlo 5912 BL
The Netherlands
+31 (0)77 3205730
f.derriks@alumni.maastrichtuniversity.nl
Inclusion criteria
1. Neonates younger that 28 days;
2. Iv for drug administration.
Exclusion criteria
Clinical indication for fluid administration apart from drug administration.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1990 |
NTR-old | NTR2107 |
Other | : |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |